JACQUELINE RAMIREZ: Open Payments
NPI 1003317256 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 55 payments from 16 companies in 2025. Trend: 2023 $1,838 · 2024 $866 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $286 |
| Janssen Biotech, Inc. | 9 | $260 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $219 |
| Madrigal Pharmaceuticals | 3 | $98 |
| Ethicon US, LLC | 1 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Ardelyx, Inc. | 4 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Celltrion USA Inc. | 2 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, LINX REFLUX MANAGEMENT SYSTEM, IBSRELA, RINVOQ, ZENPEP, ENTYVIO.
Industry payments across VA — which companies pay providers there.
